INSYS Therapeutics Inc. (INSY)

0.88
NASDAQ : Health Technology
Prev Close 0.82
Day Low/High 0.83 / 0.92
52 Wk Low/High 0.79 / 11.65
Avg Volume 1.15M
Exchange NASDAQ
Shares Outstanding 74.57M
Market Cap 61.26M
EPS -1.70
P/E Ratio N/A
Div & Yield N.A. (N.A)
These 3 Marijuana-Related Stocks Are Poised for Strong Growth

These 3 Marijuana-Related Stocks Are Poised for Strong Growth

The medical marijuana business should rack up smoking gains. We've pinpointed the three stocks that will benefit the most.

'Mad Money' Lightning Round: I Believe in Cypress Semiconductor

'Mad Money' Lightning Round: I Believe in Cypress Semiconductor

Cramer says stay away from Prospect Capital but buy WebMD Health.

Jim Cramer's 'Mad Money' Recap: These Winning Stocks Fit the Buying Pattern

Jim Cramer's 'Mad Money' Recap: These Winning Stocks Fit the Buying Pattern

The rolling bear market is getting replaced by something new, a revolving bull market, Cramer says.

Notable Tuesday Option Activity: INSY, SWN, SNAK

Notable Tuesday Option Activity: INSY, SWN, SNAK

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Insys Therapeutics Inc , where a total volume of 4,944 contracts has been traded thus far today, a contract volume which is representative of approximately 494,400 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 56% of INSY's average daily trading volume over the past month, of 882,400 shares.

Insys Therapeutics (INSY) Stock Tanks on Preliminary Subsys Revenues

Insys Therapeutics (INSY) Stock Tanks on Preliminary Subsys Revenues

Insys Therapeutics (INSY) stock is plummeting in late-afternoon trading on Monday after the company reported preliminary first quarter revenues for its Subsys treatment.

Endo International Tumbles as Insys Expects Weak Painkiller Sales

Endo International Tumbles as Insys Expects Weak Painkiller Sales

Shares of Endo fell as much as 9% Monday in sympathy with Insys Therapeutics, which pre-announced sharply weaker first-quarter sales of its fentanyl painkiller Subsys.

Trade-Ideas: Insys Therapeutics (INSY) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Insys Therapeutics (INSY) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a weak on high relative volume candidate

April 4 Deadline Alert: Law Offices Of Howard G. Smith Reminds Investors Of The Upcoming Lead Plaintiff Deadline In The Class Action Lawsuit Against Insys Therapeutics, Inc. And Encourages Investors To Contact The Firm

April 4 Deadline Alert: Law Offices Of Howard G. Smith Reminds Investors Of The Upcoming Lead Plaintiff Deadline In The Class Action Lawsuit Against Insys Therapeutics, Inc. And Encourages Investors To Contact The Firm

Law Offices of Howard G. Smith reminds investors of the upcoming  April 4, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Insys Therapeutics, Inc.

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of INSYS Therapeutics, Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of April 4, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of INSYS Therapeutics, Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of April 4, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of INSYS Therapeutics, Inc.

Today's Perilous Reversal Stock: Insys Therapeutics (INSY)

Today's Perilous Reversal Stock: Insys Therapeutics (INSY)

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a "perilous reversal" (up big yesterday but down big today) candidate

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving INSYS Therapeutics, Inc. And A Lead Plaintiff Deadline Of April 4, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving INSYS Therapeutics, Inc. And A Lead Plaintiff Deadline Of April 4, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Arizona on behalf of investors who purchased INSYS Therapeutics, Inc.

INSY INVESTOR REMINDER: Class Action Deadline Reminder From Lieff Cabraser For Investors In Insys Therapeutics, Inc.

INSY INVESTOR REMINDER: Class Action Deadline Reminder From Lieff Cabraser For Investors In Insys Therapeutics, Inc.

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in securities class litigation brought on behalf of investors who purchased...

Insys Therapeutics (INSY) In A Perilous Reversal

Insys Therapeutics (INSY) In A Perilous Reversal

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a "perilous reversal" (up big yesterday but down big today) candidate

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of INSYS Therapeutics, Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of April 4, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of INSYS Therapeutics, Inc. Of Class Action Lawsuit And A Lead Plaintiff Deadline Of April 4, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of INSYS Therapeutics, Inc.

Galena Not Named Target of Federal Criminal Probe Into Painkiller Use

Galena Not Named Target of Federal Criminal Probe Into Painkiller Use

Galena isn't the target of a criminal investigation that has already led to the arrests of two doctors, charged with allegedly running a fraudulent painkiller pill mill and taking kickbacks.

GPM Announces The Filing Of A Securities Class Action On Behalf Of Insys Therapeutics, Inc. Investors

GPM Announces The Filing Of A Securities Class Action On Behalf Of Insys Therapeutics, Inc. Investors

Glancy Prongay & Murray LLP ("GPM") announces the filing of a class action lawsuit on behalf of investors who purchased Insys Therapeutics, Inc.

Insys Therapeutics (INSY) Highlighted As Weak On High Volume

Insys Therapeutics (INSY) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a weak on high relative volume candidate

Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In INSYS Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In INSYS Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Arizona on behalf of...

INSY INVESTORS NOTICE: Lieff Cabraser Reminds Investors Of Deadline In Class Action Against Insys Therapeutics, Inc.

INSY INVESTORS NOTICE: Lieff Cabraser Reminds Investors Of Deadline In Class Action Against Insys Therapeutics, Inc.

The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in securities class litigation brought on behalf of investors who purchased...

Scott + Scott, LLP Reminds Investors Of April 4, 2016 Deadline To File Lead Plaintiff Papers In Insys Therapeutics (INSY) Securities Case

Scott + Scott, LLP Reminds Investors Of April 4, 2016 Deadline To File Lead Plaintiff Papers In Insys Therapeutics (INSY) Securities Case

Scott + Scott, Attorneys at Law, LLP, a global investor rights law firm, reminds investors that April 4, 2016 is the last day to file lead plaintiff papers in the securities lawsuit against Insys Therapeutics, Inc.

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving INSYS Therapeutics, Inc. And A Lead Plaintiff Deadline Of April 4, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Involving INSYS Therapeutics, Inc. And A Lead Plaintiff Deadline Of April 4, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Arizona on behalf of investors who purchased INSYS Therapeutics, Inc.

The Former Attorney General Of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors Of Lead Plaintiff Deadline In Class Action Lawsuit Against Insys Therapeutics, Inc.

The Former Attorney General Of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors Of Lead Plaintiff Deadline In Class Action Lawsuit Against Insys Therapeutics, Inc.

Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.

Scott + Scott, LLP Reminds Investors Of April 4, 2016 Deadline To File Lead Plaintiff Papers In Insys Therapeutics, Inc. (INSY) Securities Case

Scott + Scott, LLP Reminds Investors Of April 4, 2016 Deadline To File Lead Plaintiff Papers In Insys Therapeutics, Inc. (INSY) Securities Case

Scott + Scott, Attorneys at Law, LLP, a global investor rights law firm, reminds investors that April 4, 2016 is the last day to file lead plaintiff papers in the securities lawsuit against Insys Therapeutics, Inc.

GPM Announces The Filing Of A Securities Class Action On Behalf Of Insys Therapeutics, Inc. Investors

GPM Announces The Filing Of A Securities Class Action On Behalf Of Insys Therapeutics, Inc. Investors

Glancy Prongay & Murray LLP ("GPM") announces the filing of a class action lawsuit on behalf of investors who purchased Insys Therapeutics, Inc.

Insys Therapeutics (INSY) Highlighted As Today's Perilous Reversal Stock

Insys Therapeutics (INSY) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Insys Therapeutics (INSY) as a "perilous reversal" (up big yesterday but down big today) candidate

First Week of April 15th Options Trading For Insys Therapeutics (INSY)

First Week of April 15th Options Trading For Insys Therapeutics (INSY)

Investors in Insys Therapeutics Inc saw new options begin trading this week, for the April 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the INSY options chain for the new April 15th contracts and identified one put and one call contract of particular interest.

TheStreet Quant Rating: D (Sell)